Antonio Silvestre

Prof. Antonio Silvestre

Orthopaedic surgery, University of Valencia, Valencia, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2013 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
Antonio SilvestreAntonio Silvestre
Antonio Silvestre
FAFernando Almeida
Fernando Almeida
PRPablo Renovell
Pablo Renovell
EMElena Morante
Elena Morante
RLRaúl López
Raúl López
Silvestre A, et al. Clin Orthop Surg. 2013 Sep;5(3):180-187. http://dx.doi.org/10.4055/cios.2013.5.3.180

27 April 2020 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
FDFernando Domínguez‐Navarro
Fernando Domínguez‐Navarro
Antonio SilvestreAntonio Silvestre
Antonio Silvestre
CICeledonia Igual‐Camacho
Celedonia Igual‐Camacho
BDBeatriz Díaz Díaz
Beatriz Díaz Díaz
JTJose Vicente Torrella
Jose Vicente Torrella
JBJosé María Blasco
José María Blasco

20 September 2021 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
ISIsabel Guillén Salazar
Isabel Guillén Salazar
MTMiguel Tofiño-Vian
Miguel Tofiño-Vian
Antonio SilvestreAntonio Silvestre
Antonio Silvestre
MCMiguel Angel Castejón
Miguel Angel Castejón
MAMaria José Alcaraz
Maria José Alcaraz
Osteoarthritis (OA) is a joint disease characterized by cartilage degradation, low-grade synovitis and subchondral bone alterations. In the damaged joint, there is a progressive increase of oxidative stress leading to disruption of chondrocyte homeostasis. The modulation of oxidative stress could control the expression of inflammatory and catabolic mediators involved in OA. We have previously demonstrated that extracellular vesicles (EVs) present in the secretome of human mesenchymal stem cells from adipose tissue (AD-MSCs) exert anti-inflammatory and anti-catabolic effects in OA chondrocytes. In the current work, we have investigated whether AD-MSC EVs could regulate oxidative stress in OA chondrocytes as well as the possible contribution of peroxiredoxin 6 (Prdx6). Microvesicles (MV) and exosomes (EX) were isolated from AD-MSC conditioned medium by differential centrifugation with size filtration. The size and concentration of EVs were determined by resistive pulse sensing. OA chondrocytes were isolated from knee articular cartilage of advanced OA patients. 4-Hydroxynonenal adducts, IL-6 and MMP-13 were determined by enzyme-linked immunosorbent assay. Expression of Prdx6 and autophagic markers was assessed by immunofluorescence and Western blotting. Prdx6 was downregulated in AD-MSCs by transfection with a specific siRNA. MV and to a lesser extent EX significantly reduced the production of oxidative stress in OA chondrocytes stimulated with IL-1β. Treatment with MV resulted in a dramatic upregulation of Prdx6. MV also enhanced the expression of autophagy marker LC3B. We downregulated Prdx6 in AD-MSCs by using a specific siRNA and then MV were isolated. These Prdx6-silenced MV failed to modify oxidative stress and the expression of autophagy markers. We also assessed the possible contribution of Prdx6 to the effects of MV on IL-6 and MMP-13 production. The reduction in the levels of both mediators induced by MV was partly reverted after Prdx6 silencing. Our results indicate that EVs from AD-MSCs regulate the production of oxidative stress in OA chondrocytes during inflammation. Prdx6 may mediate the antioxidant and protective effects of MV. The translational potential of this article: This study gives insight into the protective properties of EVs from AD-MSCs in OA chondrocytes. Our findings support the development of novel therapies based on EVs to prevent or treat cartilage degradation.

Jose Casaña GranellJose Casaña Granell
Jose Casaña Granell
Joaquín CalatayudJoaquín Calatayud
Joaquín Calatayud
Antonio SilvestreAntonio Silvestre
Antonio Silvestre
JSJosé Sánchez-Frutos
José Sánchez-Frutos
LALars Louis Andersen
Lars Louis Andersen
Yasser AlakhdarYasser Alakhdar
Yasser Alakhdar
Knee osteoarthritis is a chronic joint disease which damages articular cartilage. In its severe stages, it results in impairments in balance and muscle strength loss, which affect daily life activities such as walking or climbing stairs. This study sought to investigate associated factors with stair-climbing ability in this population, with special interest in measuring the relevance of postural balance for this task. Forty-four patients scheduled to undergo unilateral total knee arthroplasty were assessed. Timed up and go test, stair ascent–descent test, three different isometric strength tests (knee flexion, knee extension and hip abduction), active knee extension and flexion range of movement and static postural balance assessment were evaluated. Spearman’s correlation coefficients and multiple linear regression analysis determined the strength of association between the different variables and stair-climbing time. No significant association between the stair-climbing time and static balance was found. Significant associations were found between stair-climbing time and timed up and go (r = 0.71; p < 0.0001) and maximal knee extensor strength (r = –0.52; p = 0.0003). One-year increase in age was associated with 0.15 s (95% CI 0.00 to 0.30) slower stair-climbing time. In conclusion, muscle strength is more important than postural balance for stair-climbing ability in this population.

Verified
Journal Article
Open access
PDF file
Paloma Guillem-LlobatPaloma Guillem-Llobat
Paloma Guillem-Llobat
MVMARTA MARIN VÁZQUEZ
MARTA MARIN VÁZQUEZ
MRMatthieu Rouleau
Matthieu Rouleau
Antonio SilvestreAntonio Silvestre
Antonio Silvestre
CBClaudine Blin-Wakkach
Claudine Blin-Wakkach
Lidia IbáñezLidia Ibáñez
Lidia Ibáñez
Osteoarthritis (OA) is a degenerative condition of the articular cartilage with chronic low-grade inflammation. Monocytes have a fundamental role in the progression of OA, given their implication in inflammatory responses and their capacity to differentiate into bone-resorbing osteoclasts (OCLs). This observational–experimental study attempted to better understand the molecular pathogenesis of OA through the examination of osteoclast progenitor (OCP) cells from both OA patients and healthy individuals (25 OA patients and healthy samples). The expression of osteoclastogenic and inflammatory genes was analyzed using RT-PCR. The OA monocytes expressed significantly higher levels of CD16, CD115, TLR2, Mincle, Dentin-1, and CCR2 mRNAs. Moreover, a flow cytometry analysis showed a significantly higher surface expression of the CD16 and CD115 receptors in OA vs. healthy monocytes, as well as a difference in the distribution of monocyte subsets. Additionally, the OA monocytes showed a greater osteoclast differentiation capacity and an enhanced response to an inflammatory stimulus. The results of this study demonstrate the existence of significant differences between the OCPs of OA patients and those of healthy subjects. These differences could contribute to a greater understanding of the molecular pathogenesis of OA and to the identification of new biomarkers and potential drug targets for OA.